Construct · 1 fields · 1 citations

debrisoquine hydroxylation polymorphism: a standalone construct

One name. One construct. A landmark on the map.

● anchor · a standalone construct Nearest construct by meaning·not indexed
debrisoquinehydroxylation polymorphism1 CONSTRUCTDebrisoquineMAHGOUB · PHARMACOGENOMICS

A single standalone construct; nearby constructs are located against it in the Collider. Tap a field for its definition, unit, and measures.

Pharmacogenomics

an inherited difference in the ability to oxidize debrisoquine, splitting people into extensive and poor metabolizers of many drugs.

In pharmacogenomics, debrisoquine hydroxylation polymorphism refers to an inherited difference in the ability to oxidize debrisoquine, splitting people into extensive and poor metabolizers of many drugs. This meaning comes from Mahgoub (1977) in The Lancet.[1]

Unit
Recovery means
Measured by

Next

Run it through the Collider, or take the citations with you.

See how debrisoquine hydroxylation polymorphism sits against neighbouring constructs in the Collider, or export every reference on this page in one click.

Open in ColliderExport BibTeXReport this entry

Nearby constructs

pharmacogenomics1 fields · 1 citationsanchor · a standalone constructpolymorphism4 fields · 7 citationsjingle · one word, four fields

References

  1. Mahgoub, A., Dring, L. G., Idle, J. R., Lancaster, R., & Smith, R. L. (1977). Polymorphic Hydroxylation of Debrisoquine in Man. The Lancet, 310(8038), 584-586. https://doi.org/10.1016/s0140-6736(77)91430-1

Cited on this page?

Confirm your construct, or correct us.

If your work is cited behind one of these entries, you know better than we do whether we captured the meaning right. Confirm it, suggest an edit, or dispute it, and your name goes on the entry as an author who has checked it, linked to your ORCID.

Claim your construct